Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease
Moira Marizzoni(Centro San Giovanni di Dio Fatebenefratelli), Giovanni B. Frisoni(University of Geneva)
Cited by 318
Related Papers
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
|Neurology|2016|1.9k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
|The Lancet Neurology|2017|630